Find Academic Supervisors

Deeksha Katoch is a Clinical Fellow in Pediatric Hematology-Oncology at Yale School of Medicine, specializing in benign hematology and bleeding disorders with a focus on improving patient care in resource-limited settings. She is actively engaged in research and clinical practice within Yale's Department of Pediatric Hematology & Oncology. Her educational background includes: MHS in Clinical Informatics and Data Science from Yale School of Medicine (2026) Chief Residency at SUNY Downstate Health Science University (2023) Residency at SUNY Downstate Health Science University (2022) MBBS from Government Medical College, Jammu Board Certified in General Pediatrics by the American Board of Pediatrics (2022) Dr. Katoch's research spans pediatric hematology-oncology, retinal disorders, and bleeding disorders, with particular interest in sickle cell disease, hematopoietic cell transplantation, and diabetic retinopathy. Her work combines clinical practice with innovative research approaches, including the application of GIS to assess healthcare access impacts on bleeding disorder outcomes. Her publications demonstrate expertise in both clinical research and the intersection of ophthalmology with hematology. Her significant scientific recognitions include: Dataset Research Engagement and ATHN Mentorship (DREAM) award from Hemostasis & Thrombosis Research Society/American Thrombosis and Hemostasis Network Member of American Society of Pediatric Hematology-Oncology Travel Grant Award from American Society of Transplantation and Cellular Therapies Abstract Achievement Award from American Society of Hematology Patient Care Trust Fund (PCTF) Award from Committee of Interns and Residents/NYC Health & Hospitals Dr. Katoch is actively involved in professional organizations including the American Academy of Pediatrics, American Society of Hematology, American Society of Pediatrics Hematology-Oncology, and American Society of Transplantation and Cellular Therapies. Her clinical fellowship combines her previous military medical experience as a Medical Officer in the Indian Air Force with advanced pediatric hematology-oncology training. She maintains active research collaborations with Yale colleagues including Dr. Lakshmanan Krishnamurti, Dr. Nitya Bakshi, and Jingchen Liang.

• Pediatric Hematology
• Oncology
• Bleeding Disorders
• +5 more

Kakarla Chalam, MD, PhD, MBA, FACS holds multiple academic and leadership positions at Loma Linda University School of Medicine, where he serves as Professor of Ophthalmology, Professor in the Regenerative Medicine Division of Medicine, and Professor in the Pharmacology Division of Basic Sciences. His institutional roles include Vice Chair of Academic Affairs for Ophthalmology, Director of Medical Student Education in Ophthalmology, Director of the Retina Program, and Program Director for the Retina Fellowship. Dr. Chalam's research spans multiple areas of ophthalmology with a primary focus on retinal diseases and surgical interventions. His work encompasses diabetic retinopathy imaging and treatment, macular hole repair techniques, vitrectomy innovations including "dropless" approaches, and the application of artificial intelligence to ophthalmic imaging. He has pioneered research in optical coherence tomography applications, ultrawidefield angiography, and novel surgical techniques for complex retinal conditions. His publication record demonstrates consistent scholarly output with 227 research contributions from 1985 through 2025, showing particularly robust activity in recent years with publications spanning clinical trials, surgical innovations, imaging technology advancements, and case reports of complex ocular conditions. His research shows a clear trajectory toward integrating advanced imaging technologies with artificial intelligence applications for improved diagnosis and treatment of retinal diseases. Dr. Chalam has participated in significant multicenter clinical trials including the DRCR Retina Network studies and the Ischemic Optic Neuropathy Decompression Trial. His work has appeared in high-impact journals including JAMA, Ophthalmology, and JAMA Ophthalmology, reflecting the significance of his contributions to the field. As Program Director for the Retina Fellowship and Director of Medical Student Education in Ophthalmology, he plays a key role in training the next generation of ophthalmologists. His leadership positions indicate recognition of his expertise by the institution across both clinical and academic domains.

• Ophthalmology
• Retinal Diseases
• Diabetic Retinopathy
• +4 more

Craig J. Chaya, MD , is Associate Professor (Clinical) of Ophthalmology at the University of Utah and serves as Division Chief of Global Ophthalmology at the John A. Moran Eye Center. He practices anterior segment ophthalmology and surgery across multiple clinical sites including the University of Utah flagship campus, Redwood and Midvalley Health Centers, Salt Lake Veterans Medical Center, and Primary Children’s Medical Center. Education & Training: MD – Loma Linda University School of Medicine, Loma Linda, CA BS – La Sierra University, Riverside, CA (Human Biology) Residency – Internal Medicine, West Los Angeles VA Medical Center Residency – Ophthalmology, Texas Tech University Health Sciences Center Fellowship – Glaucoma, University of Utah / John A. Moran Eye Center Fellowship – International Ophthalmology, Himalayan Cataract Project/Freedom Foundation (Kathmandu & Hetauda, Nepal) Clinical & Research Focus Dr. Chaya specializes in the medical and surgical management of complex cataracts and glaucoma, emphasizing micro-invasive glaucoma surgery (MIGS) and novel surgical devices. He is deeply engaged in global ophthalmology, directing international outreach and blindness-prevention programs across Guam, Micronesia, Ghana, Haiti, Thailand, and Nepal. His research portfolio includes prospective surgical outcome studies, epidemiologic analyses of exfoliation syndrome, and innovative techniques such as gonioscopy-assisted transluminal trabeculotomy (GATT). Selected Publication Themes Recent peer-reviewed work spans three major domains: (1) refinement of trabeculotomy and cyclodialysis techniques to improve safety and efficacy in glaucoma surgery, (2) epidemiologic and genetic investigations into exfoliation syndrome and glaucoma among underserved populations, and (3) development of global ophthalmology training curricula and COVID-19-adapted outreach models. Scientific & Professional Recognition Board Certified, American Board of Ophthalmology Associate Professor (Clinical), University of Utah Department of Ophthalmology & Visual Sciences Division Chief, Global Ophthalmology, John A. Moran Eye Center Teaching & Mentorship Dr. Chaya supervises residents and fellows in complex anterior segment surgery and global ophthalmology rotations. He contributes to Moran CORE educational videos and lectures on MIGS techniques and international surgical outreach.

• Glaucoma surgery
• Cataract surgery
• Anterior segment ophthalmology
• +4 more

Karim Hammamji is a Clinical Assistant Professor in the Department of Ophthalmology at Université de Montréal 's Faculty of Medicine. As a vitreoretinal surgeon, he specializes in medical and surgical retina with a focus on ocular oncology at the Centre Hospitalier de l'Université de Montréal (CHUM) . He leads the retina division and directs CHUM's vitreoretinal fellowship program.

• Medical and Surgical Retina
• Ocular Oncology
• Macular Degeneration
• +3 more

Aman Chandra is a consultant ophthalmic and vitreoretinal surgeon, Honorary Visiting Fellow at the Vision and Eye Research Institute (Faculty of Health, Medicine and Social Care, School of Medicine), and an active researcher in retinal diseases and zonular disorders. He holds affiliations with institutions including the Mid & South Essex NHS Foundation Trust, Royal College of Ophthalmologists, Royal College of Surgeons of Edinburgh, and international societies like EURETINA and American Society of Retinal Specialists. Clinical Training: Moorfields Eye Hospital (London), Royal Victoria Eye & Ear Hospital (Melbourne) Education: PhD in Genetics of Rhegmatogenous Retinal Detachment & Ectopia Lentis (University College London, Institute of Ophthalmology), MBBS (Guy’s, King’s & St Thomas’ Hospitals), BSc (Pharmacology, King’s College London) Research Interests focus on retinal diseases, zonular disorders, and their genetic underpinnings. He has led clinical trials, secured over £100,000 in grants, and collaborated globally across the USA, India, Australia, and the UK. His work intersects ophthalmology, molecular genetics, and surgical education. Recent Publications highlight trends in vitreoretinal surgery during the COVID-19 pandemic, genetic studies of retinal detachment, and surgical training methodologies. Key keywords include ophthalmic genetics, retinal surgery, and clinical trial design. Scientific Awards include the prestigious Syme Medal (2015) from the Royal College of Surgeons of Edinburgh, Fight For Sight Small Project Award, Ethicon and Pfizer Travel Awards, and significant grant funding. Teaching & Leadership : He develops and leads clinical courses at Anglia Ruskin University (ARU), national meetings, and international conferences. Roles include Surgical Trainer (Royal College of Ophthalmologists), Simulation Trainer (European School for Advanced Studies in Ophthalmology), and Faculty on Get it Flat course (American Society of Retinal Specialists). Labs & Teams : Collaborates globally with institutions in the USA, India, Australia, and UK. Served as Ophthalmology Council Member (Royal Society of Medicine), Awards and Scholarships Lead (Royal College of Ophthalmologists), and Immediate Past Research Lead for BEAVRS. He reviews manuscripts for Eye , IOVS , and other journals.

• Ophthalmology
• Vitreoretinal Surgery
• Retinal Diseases
• +4 more

Ghassan Cordahi serves as a Clinical Assistant Professor in the Department of Ophthalmology at the Faculty of Medicine, University of Montreal. He is affiliated with the RRSV (Research Network in Vision Health) and the CIUSSS de l'Est-de-l'Île-de-Montréal – Hôpital Maisonneuve-Rosemont (HMR). His clinical and research work focuses on the visual system, particularly retinal diseases and surgical interventions. Dr. Cordahi's research interests center on ophthalmology with a strong emphasis on retinal diseases, vision science, macular disorders, retinal detachment, and ocular surgery. His work spans clinical investigations, surgical techniques, and therapeutic interventions for various eye conditions. He has contributed significantly to understanding surgical outcomes, treatment modalities, and pathophysiological mechanisms in retinal disorders. Analysis of Dr. Cordahi's publication record reveals a consistent focus on retinal diseases and surgical interventions over more than two decades. His research trajectory shows evolution from basic surgical techniques in the early 2000s toward more sophisticated treatment approaches and long-term outcome studies in recent years. Key themes include retinal detachment management, macular disorders, anti-VEGF therapies, and surgical complications. His work often combines clinical observations with technological applications like optical coherence tomography. Dr. Cordahi has collaborated extensively with colleagues at the University of Montreal and affiliated institutions, contributing to numerous studies in high-impact ophthalmology journals. His research demonstrates a commitment to improving surgical outcomes and understanding the physiological mechanisms underlying various retinal conditions.

• Ophthalmology
• Retinal Diseases
• Vision Science
• +3 more

Miss Pim Doungsong is a Researcher and PhD candidate in Health Economics at Bangor University ’s School of Health Sciences . Her work focuses on economic evaluations of healthcare interventions, particularly for dementia care and geriatric conditions. Qualifications : MSc in Public Health and Health Promotion (2021–2022); Doctor of Pharmacy (Pharmaceutical Care), Chiang Mai University (2018). Research Themes : Health economics, social return on investment (SROI), cost-consequence analysis, community-based interventions, and clinical trial evaluations. Key Activities : Oral/poster presentations at UCL Economics evaluations (2025), HESG (2023), and SAPC (2024) conferences. Funding : Supported by the National Institute for Health Research (NIHR) Programme Grants for Applied Health Research (RP-PG-0614-20007). Research Trends : Her publications emphasize the societal and economic impacts of healthcare programs, including dementia management, post-hip fracture rehabilitation, and ophthalmological treatments. Keywords span Health Economics , Geriatric Medicine , Medical Research , and Clinical Trials , with sub-fields like Cost-Effectiveness Analysis , Remote Healthcare Delivery , and Surgical Interventions . Collaborations : Works with institutions such as the University of Nottingham and the National Health Service (NHS), with peer-reviewed preprints on medRxiv and conference presentations.

• Health Economics
• Dementia
• Economic Evaluation
• +3 more

Prof. Dr. Hasan Basri Arifoğlu is an Associate Professor at Okan University Faculty of Medicine, Department of Ophthalmology, specializing in Medical Retina and Vitreoretinal Surgery. He has been actively contributing to ophthalmology research and clinical practice since completing his specialist training in 2010. Graduated from Erciyes University Faculty of Medicine Completed specialist training at SB Ankara Atatürk Training and Research Hospital (2010) Completed compulsory service at Ulucanlar Eye Training and Research Hospital and Rize Kaçkar State Hospital Participated in preceptorship program at University of Chicago Vitreoretinal Surgery Unit (2015) Attended EVRS fellowship course in Bremen (2016) Appointed Associate Professor at Okan University Faculty of Medicine (2017) Dr. Arifoğlu's research primarily focuses on Medical Retina and Vitreoretinal Surgery, with significant contributions to understanding retinal diseases, vitreoretinal surgical techniques, and ocular imaging. His work explores the relationship between systemic conditions and ocular manifestations, particularly in areas such as choroidal thickness changes, diabetic retinopathy, and age-related macular degeneration. He has pioneered research on the effects of physiological maneuvers like Valsalva on ocular structures and has contributed to advancements in corneal crosslinking techniques for pediatric keratoconus. His extensive publication record demonstrates expertise across multiple ophthalmological subspecialties, with particular emphasis on retinal vascular diseases, macular disorders, and innovative surgical approaches. Dr. Arifoğlu has published over 25 articles in international refereed journals and presented at numerous international conferences, accumulating 99 citations according to Web of Science and Google Scholar. Gazi Eye Foundation Scientific Incentive Award (2014) EVRS European Vitreoretinal Training School Certification (2016) Dr. Arifoğlu has been actively involved in numerous research collaborations and has supervised multiple studies examining the relationship between systemic diseases and ocular manifestations. His work often involves multidisciplinary approaches, collaborating with cardiology, hematology, and obstetrics specialists to understand how systemic conditions affect ocular structures. He has been instrumental in establishing protocols for evaluating choroidal thickness changes in various clinical scenarios and has contributed to refining vitreoretinal surgical techniques. Through his affiliation with Okan University Hospital, Dr. Arifoğlu leads a research team focused on advancing vitreoretinal diagnostics and therapeutics. His laboratory utilizes state-of-the-art imaging technologies including spectral-domain optical coherence tomography to investigate retinal and choroidal pathologies. The team is currently exploring innovative approaches to managing macular edema and optimizing outcomes for patients with retinal vascular diseases.

• Medical Retina
• Vitreoretinal Surgery
• Ophthalmology
• +3 more

Colin A. McCannel is a Clinical Professor of Ophthalmology at the University of California, Los Angeles (UCLA) Stein Eye Institute . With clinical expertise in vitreoretinal surgical conditions—including complex retinal detachments, macular holes, epimacular membranes, diabetic retinopathy, and age-related macular degeneration (AMD)—he combines advanced surgical practice with innovative research initiatives. MD from Mayo Medical School Residency & Retina Fellowship at UCLA Faculty at Stein Eye Institute since 2008 Research Focus : Outcomes research in retinal surgery, endophthalmitis prevention, and virtual reality (VR) surgical training integration. He pioneered VR into ophthalmology residency and fellowship curricula, revolutionizing skill acquisition. Article Trends (2022-2025) span AMD management, radiation retinopathy, intraocular lymphoma, and surgical simulation. Keywords include Ophthalmology , Retinal Surgery , and Medical Education , with sub-fields like Anti-VEGF Therapy and Gene Expression Profiling . Scientific Awards highlight his leadership: multiple American Academy of Ophthalmology honors (2016 Senior Achievement Award), Innovation in Education (2008), and early career fellowships (Heed, Jules Stein). He serves as a core lecturer at the European Vitreoretinal Training School since 2002. Virtual Reality Initiatives at Stein Eye Institute demonstrate his commitment to surgical education. His work bridges clinical excellence with technological innovation, ensuring trainees master procedures like 27-gauge vitrectomy and McCannel Plaque Stitch techniques.

• Outcomes Research
• Endophthalmitis
• Epidemiology of Ophthalmic Disease
• +5 more

Kakarla V. Chalam, MD, PhD, MBA, FACS is a Professor of Ophthalmology at Loma Linda University School of Medicine, holding multiple leadership positions including Vice Chair of Academic Affairs, Director of Medical Student Education in Ophthalmology, Director of the Retina Program, and Program Director of the Retina Fellowship. His academic appointments also span the Regenerative Medicine Division in Medicine and the Pharmacology Division in Basic Sciences, demonstrating his interdisciplinary expertise. Dr. Chalam earned his Master of Business Administration from Webster University in 1999, complementing his medical and scientific training. His educational background supports his leadership roles in academic medicine and program administration. Dr. Chalam's research focuses on ophthalmology with particular emphasis on retinal diseases, diabetic retinopathy, vitreoretinal surgery, and advanced imaging techniques. His work bridges clinical practice with technological innovation, as evidenced by his recent publications on AI applications in ophthalmic imaging and novel surgical techniques for macular disorders. He has made significant contributions to the understanding and treatment of diabetic retinopathy, macular holes, and other retinal conditions, with numerous publications in high-impact ophthalmology journals. An analysis of his recent publications (2022-2025) reveals a strong focus on practical surgical innovations (particularly "dropless vitrectomy" techniques), advanced imaging methodologies for retinal diseases, and the application of artificial intelligence to ophthalmic diagnostics. His work often addresses clinical challenges in diabetic retinopathy management and macular disorders, with an emphasis on improving surgical outcomes and diagnostic precision. As Program Director of the Retina Fellowship, Dr. Chalam plays a critical role in training the next generation of vitreoretinal specialists. His leadership extends to directing medical student education in ophthalmology, shaping curricula and clinical experiences for future physicians. Dr. Chalam's laboratory and clinical work appears to center around retinal imaging, surgical innovation, and diabetic eye disease research. His recent publications involving OCT angiography, ultrawidefield imaging, and novel surgical techniques suggest an active research program focused on improving diagnostic capabilities and treatment outcomes for retinal conditions.

• Ophthalmology
• Retinal Diseases
• Diabetic Retinopathy
• +5 more

Siegfried Wagner is an Honorary Clinical Senior Research Fellow at the University College London's Institute of Ophthalmology, affiliated with the NIHR Biomedical Research Centre at Moorfields Eye Hospital and UCL. He holds roles such as MRC Clinical Research Training Fellow and NIHR Academic Clinical Fellow, with appointments spanning from 2020 to 2100. His education includes a PhD in Ophthalmology (UCL, 2023), MSc in Epidemiology (London School of Hygiene and Tropical Medicine, 2022), and earlier degrees from the University of Oxford (BM BCh in Clinical Medicine, 2012; BA in Medical Sciences, 2009). His research focuses on Ophthalmology and Optometry , Clinical Sciences , Immunology , Biomedical Engineering , and Health Services and Systems . Key interests include leveraging AI for retinal imaging diagnostics, linking ocular biomarkers to systemic diseases like cardiovascular disorders and neurodegenerative conditions, and developing open-source tools like AutoMorph and RETIMAT . He explores topics such as retinal vascular morphology, synthetic data privacy in medical research, and the role of retinal imaging in predicting conditions like dementia and Parkinson’s disease. Wagner’s scientific awards include Fellowships from the European Board of Ophthalmology (FEBO), Membership from the Royal College of Physicians (MRCP), and Fellowship from the Royal College of Ophthalmologists (FRCOphth). His work emphasizes ethical AI deployment in healthcare, as seen in initiatives like CARE-AI , and addresses barriers in telemedicine adoption through studies on patient demographics and non-attendance factors. His grants include MRC and NIHR funding for clinical research training. While no formal advisees are listed, he collaborates extensively in interdisciplinary teams. He leads projects integrating multimodal imaging with genetic and clinical data, such as Eye2Gene and SynthEye , to advance gene diagnosis and synthetic data applications in inherited retinal diseases. Labs and teams: Core contributor to the AlzEye study, which links ophthalmic imaging to neurodegenerative diseases. Active in developing AutoMorph , an AI-driven pipeline for retinal vessel analysis, and RETIMAT , an open-source OCT analysis software. Collaborates with global institutions via the Collaboration Network X (Twitter).

• Ophthalmology and Optometry
• Clinical Sciences
• Immunology
• +2 more

Timothy Jackson is a Professor of Retinal Research in the Department of Ophthalmology . He is an internationally recognized clinician-scientist specializing in retinal diseases, macular degeneration, and advanced retinal surgical techniques. His work bridges clinical ophthalmology and translational research, with a strong focus on improving outcomes for patients with complex retinal conditions. Education & Academic Standing: Professor of Retinal Research, Ophthalmology HEFCE Clinical Senior Lectureship Award (2011) Research Interests: Professor Jackson’s research spans several interrelated domains: Macular Degeneration: Investigating wet and dry forms of age-related macular degeneration (AMD), including combination therapies and novel drug delivery systems. Retinal Surgery: Advancing vitrectomy techniques for macular hole, submacular hemorrhage, and epiretinal membranes. Diabetic Eye Disease: Exploring diabetic retinopathy and its systemic neurologic implications using large-scale biobank data. Glaucoma: Leading multicentre trials such as the NAMinG trial evaluating nicotinamide in glaucoma. Retinal Imaging & AI: Developing machine learning tools for automated detection of retinal pathologies like venous pulsations and hydroxychloroquine toxicity. Scientific Awards & Honors: American Academy of Ophthalmology Achievement Award (2017) American Academy of Ophthalmology Personal Achievement Award (2017) Elected to the Retina Society (USA) in 2012 Acting Treasurer, British and Eire Association of Vitreoretinal Surgeons (2010) Research Leadership & Funding: Professor Jackson has led or co-led over 20 research projects , including large-scale clinical trials and feasibility studies. Notable active projects include: TIGER Trial: A European multicentre RCT evaluating vitrectomy and subretinal tPA for submacular hemorrhage in AMD. GEM Study: Assessing gasless macular hole surgery feasibility. NAMinG Trial: Phase III RCT of nicotinamide in glaucoma. AI in Retinal Imaging: MRC-funded project for automated detection of spontaneous venous pulsations. Diabetic Microangiopathy Platform: Diabetes UK-funded personalised drug screening project. Clinical & Academic Service: He contributes extensively to peer review and editorial roles, including for The Lancet , Ophthalmology Retina , and EURETINA . He chairs committees at Moorfields Eye Hospital NHS Foundation Trust and participates in national and international guideline development.

• Retinal Research
• Age-related Macular Degeneration
• Diabetic Retinopathy
• +7 more

Pradeep S. Prasad, MD, MBA, serves as Associate Professor of Ophthalmology in the Retina Division at UCLA Stein Eye Institute and directs the Vitreoretinal Surgery Fellowship Program. A former Chief of Ophthalmology at Harbor-UCLA Medical Center, he specializes in diabetic retinopathy, complex retinal detachments, macular degeneration, and ocular trauma management. His academic journey includes: MD from UCLA School of Medicine (2005), Alpha Omega Alpha inductee Ophthalmology residency at UCLA (2009) Vitreoretinal fellowship at Jules Stein Eye Institute (2011) MBA from UCLA Anderson School of Management with healthcare operations focus (2017) Dr. Prasad's research centers on diabetic retinopathy mechanisms, surgical innovations for retinal detachments, and ethnic variations in disease presentation. He leverages advanced imaging like optical coherence tomography to investigate treatment responses and disease progression, with growing emphasis on healthcare delivery optimization and diversity in clinical research. His work bridges laboratory discoveries with clinical applications to improve patient outcomes in retinal diseases. Analysis of his recent publications reveals dominant themes in diabetic retinopathy management (40% of articles), surgical outcomes in complex vitreoretinal cases (30%), and health system impacts on eye care delivery (20%). His research increasingly incorporates ultra-widefield imaging and explores socioeconomic factors affecting disease progression and treatment access. His accolades highlight dual excellence in clinical practice and education: Super Doctors Southern California (2023-2025) Castle Connolly Top Doctor (2023, 2024) Faculty & Fellow Teaching Awards (2011, 2015) Bausch and Lomb Retina Research Award (2011) Robert E. Christensen Research Award (2009) As Fellowship Program Director, Dr. Prasad mentors future vitreoretinal surgeons while leading multi-center clinical trials as principal investigator. His grant-funded research focuses on novel anti-VEGF therapies and surgical pathway optimization, including expedited pre-operative anesthesia protocols that reduce costs by 22% in county healthcare systems. He actively serves on journal review panels and professional society committees. Within the Stein Eye Institute's Retina Division, Dr. Prasad collaborates with multidisciplinary teams across Ronald Reagan UCLA Medical Center and UCLA Santa Monica Medical Center. His clinical operations research directly informs workflow improvements for diabetic eye disease management, with future work targeting health disparity reduction through community-based screening initiatives.

• Diabetic Retinopathy
• Retinal Detachments
• Age-related Macular Degeneration
• +3 more

ERKUT KÜÇÜK serves as an Associate Professor at Nigde Omer Halisdemir University's Faculty of Medicine, within the Department of Ophysics. His academic journey includes a medical degree from Hacettepe University (1997-2003) and specialized training in vitreoretinal surgery from Ankara Numune Training and Research Hospital (2005-2010), where his thesis focused on 23-gauge pars plana vitrectomy outcomes. He held the position of Head of Department from 2017 to 2020 and currently leads a TUBITAK 3501 project investigating diabetic retinopathy and epoxyeicosatrienoic acid metabolism. His research explores ophthalmology with emphasis on: Retinal and choroidal pathologies (e.g., macular degeneration, retinoschisis) Ocular surface disorders (dry eye syndromes, pterygium) Neuro-ophthalmic manifestations of systemic diseases (stroke, COVID-19, fibromyalgia) Pharmacological interventions for ocular fibrosis Publications (2019-2021) demonstrate a strong focus on advanced imaging techniques (OCT), inflammatory biomarkers, and epidemiological studies of visual impairment. Trends include interdisciplinary investigations linking ophthalmology with neurology, pharmacology, and genetics.

• Ophthalmology
• Retinal Diseases
• Choroidal Thickness
• +4 more

Steven Sanislo is a Clinical Professor in the Department of Ophthalmology at Stanford University School of Medicine, where he serves as the senior vitreoretinal surgeon. He maintains an active clinical practice at the Stanford Byers Eye Institute, specializing in vitreoretinal surgery and the medical treatment of complex retinal diseases, including age-related macular degeneration, diabetic retinopathy, macular holes, and retinal detachments. He is deeply involved in teaching ophthalmology residents and retina fellows, and contributes to clinical research on retinal conditions. Education and Training: Medical Education: University of Michigan School of Medicine (1991) Internship: Santa Clara Valley Medical Center (1992) Residency: Stanford University Ophthalmology Residency (1996) Fellowship: Cleveland Clinic Foundation in Vitreoretinal Surgery (1988) Board Certification: American Board of Ophthalmology (2009) Research Interests: Dr. Sanislo's research focuses on improving clinical outcomes in retinal diseases, particularly through early intervention, surgical innovation, and understanding disease progression. His work includes studies on visual acuity outcomes in retinal detachment, anti-VEGF therapy in retinopathy of prematurity, and the role of ophthalmic examination in systemic diseases like Susac syndrome. He has also contributed to operational research aimed at enhancing efficiency in retina clinics. Publication Trends: His recent publications span clinical case reports, retrospective studies, and quality improvement research. The articles emphasize timely surgical intervention, diagnostic accuracy using advanced imaging (e.g., intraoperative OCT), and systemic implications of retinal findings. Key themes include retinal detachment management, macular pathology, and interdisciplinary diagnosis. Professional Affiliations: American Academy of Ophthalmology (1998–Present) Association for Research in Vision and Ophthalmology (1998–Present) American Board of Ophthalmology, Diplomat (1988–Present) American Society of Retina Specialists (1998–Present) Retina Society (2005–Present) Advising and Grants: Dr. Sanislo mentors ophthalmology trainees through structured independent studies, including Early Clinical Experience in Ophthalmology (OPHT 280), Directed Reading (OPHT 299), and research courses for medical and undergraduate students. While specific grant funding is not detailed, his research contributions suggest involvement in clinical and translational studies supported by institutional or collaborative funding. He is actively engaged in improving patient care systems and surgical outcomes in retina. Labs and Clinical Teams: He is a key member of the Stanford Byers Eye Institute’s vitreoretinal team, contributing to both clinical care and academic leadership in retinal diseases. His work integrates closely with multidisciplinary teams in neurology, pediatrics, and immunology, especially in complex diagnostic cases.

• Ophthalmology
• Vitreoretinal Surgery
• Retinal Diseases
• +7 more